๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma

โœ Scribed by Urakami, Shinji; Fujii, Yasuhisa; Yamamoto, Shinya; Yuasa, Takeshi; Kitsukawa, Shinichi; Sakura, Mizuaki; Yano, Akihiro; Saito, Kazutaka; Masuda, Hitoshi; Yonese, Junji; Fukui, Iwao


Book ID
120224617
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
195 KB
Volume
32
Category
Article
ISSN
1078-1439

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase I/II study of a combined gemcitabi
โœ Tetsuro Tsukamoto; Junji Yonese; Yuhei Ohkubo; Iwao Fukui ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 112 KB

## Abstract ## BACKGROUND The authors attempted to determine the maximum tolerated dose (MTD) of gemcitabine in combination with etoposide and cisplatin as a chemotherapy regimen and investigated the safety and antitumor activity with the recommended doses of gemcitabine with etoposide and cisplat

Docetaxel/cisplatin as first-line chemot
โœ Martina Baur; Heinz-Roland Kienzer; Johannes Schweiger; Maria DeSantis; Erich Ge ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 69 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND The objective of this Phase II study was to assess the clinical activity and toxicity of docetaxel (D) and cisplatin (P) in patients with locally advanced unresectable, metastatic, or recurrent squamous cell carcinoma of the head and neck (SCCHN). ## PATIENTS Of 34 pati